This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $15,249.25 issued by the Defense Logistics Agency (DLA) under the SPE2DB Indefinite Delivery Contract (IDC). The award is for the supply of 4,567,552,715 units of the Nexplanon 68 mg contraceptive implant, a specialized pharmaceutical product. The delivery order is structured as a firm fixed-price contract, with a period of performance through December 27, 2024. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group holds a significant $499,999,999 IDC with the DLA, which enables the agency to issue delivery orders for a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the medical supply needs of military healthcare facilities worldwide. This latest award demonstrates DMS Pharmaceutical Group's capability to provide specialized pharmaceutical products to the Department of Defense.
Generated 3/13/25, 9:46 AM